Surgical Mesh is Set to Rise Again Amid Safety Issues

Mar 26
09:07

2012

Kathleen Hennis

Kathleen Hennis

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

Nevertheless, a two percent increase is expected in 2012 in the number of transvaginal pelvic floor repair (PFR) procedures and sacral colpopexy/hysteropexy procedures using either a synthetic mesh or a biologic graft is predicted to increase by two percent.

mediaimage

Survey results of the United States indicated that manyphysicians show that in 2012,Surgical Mesh is Set to Rise Again Amid Safety Issues Articles surgical mesh product will rise up again.  It took a backseat in the previous year due to loss of confidence and increasing patients’ safety concerns.


The global authority on medical technology market intelligence, MRG said that market growth of surgical mesh products will increase despite loss of confidence and increasing patients' safety concerns.  Furthermore, the safety notification from the Food and Drug Administration (FDA) and recommendations from the FDA's advisory committee to change the approval process for these products will not be a hindrance of its comeback.


Surgical mesh product sales diminished due to loss of confidence and rising patient concern. Nevertheless, a two percent increase is expected in 2012 in  the number of transvaginal pelvic floor repair (PFR) procedures and sacral colpopexy/hysteropexy procedures using either a synthetic mesh or a biologic graft is predicted to increase by two percent.  Notwithstanding recent adverse events reports and reclassification of surgical mesh products as “high risk”, some companies have maintained physician’s loyalty.  Strong brand preferences were observed in most physicians based on mesh material, weight and training programs offered by surgical mesh providers.


Sohaib Perwaiz,MRG analyst, said that "Despite the recent controversy, and the fact that a large portion of physicians have reported increased patient concern about the safety and efficacy of urogynecologic surgical mesh and related procedures, many survey respondents find that surgical mesh products have distinct benefits in treating pelvic organ prolapse and stress urinary incontinence."  In line with the evolving physician and public perception, manufacturers of surgical mesh product are trying to optimize their product offerings and marketing efforts to better position themselves in the market.


A survey conducted in November and December 2011 and included 181 respondents, 130 of which were current users of synthetic surgical mesh in urogynecologic treatments and 51 were synthetic surgical mesh nonusers supported these results. Survey respondents were gynecologists, urologists and urogynecologists in the United States.


The reported adverse events that caused the filing of transvaginal mesh lawsuit by some women is not reflected on the results of the survey. Nevertheless, the discordant survey results and the increasing number of adverse events will, in no case,  give light to surgical mesh problems.